{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:36:56Z","timestamp":1791279416274,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2012,2,29]],"date-time":"2012-02-29T00:00:00Z","timestamp":1330473600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1038\/npp.2012.14","type":"journal-article","created":{"date-parts":[[2012,2,29]],"date-time":"2012-02-29T11:31:24Z","timestamp":1330515084000},"page":"1689-1698","source":"Crossref","is-referenced-by-count":206,"title":["A Proof-of-Concept Randomized Controlled Study of Gabapentin: Effects on Cannabis Use, Withdrawal and Executive Function Deficits in Cannabis-Dependent Adults"],"prefix":"10.1038","volume":"37","author":[{"given":"Barbara J","family":"Mason","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Crean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Goodell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M","family":"Light","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Quello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Shadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Buffkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Kyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murali","family":"Adusumalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Begovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,29]]},"reference":[{"key":"BFnpp201214_CR1","unstructured":"American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders, 4th edn, Text Revision. American Psychiatric Press: Washington, DC."},{"key":"BFnpp201214_CR2","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1207\/s15327752jpa6703_13","volume":"67","author":"AT Beck","year":"1996","unstructured":"Beck AT, Steer RA, Ball R, Ranieri W (1996). Comparison of beck depression inventories -IA and -II in psychiatric outpatients. J Pers Assess 67: 588\u2013597.","journal-title":"J Pers Assess"},{"key":"BFnpp201214_CR3","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.sleep.2010.02.013","volume":"11","author":"KI Bolla","year":"2010","unstructured":"Bolla KI, Lesage SR, Gamaldo CE, Neubauer DN, Wang NY, Funderburk FR et al (2010). Polysomnogram changes in marijuana users who report sleep disturbances during prior abstinence. Sleep Med 11: 882\u2013889.","journal-title":"Sleep Med"},{"key":"BFnpp201214_CR4","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1037\/0021-843X.112.3.393","volume":"112","author":"AJ Budney","year":"2003","unstructured":"Budney AJ, Moore BA, Vandrey RG, Hughes JR (2003). The time course and significance of cannabis withdrawal. J Abnorm Psychol 112: 393\u2013402.","journal-title":"J Abnorm Psychol"},{"key":"BFnpp201214_CR5","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1046\/j.1360-0443.1999.94913114.x","volume":"94","author":"AJ Budney","year":"1999","unstructured":"Budney AJ, Novy PL, Hughes JR (1999). Marijuana withdrawal among adults seeking treatment for marijuana dependence. Addiction 94: 1311\u20131322.","journal-title":"Addiction"},{"key":"BFnpp201214_CR6","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jsat.2008.01.002","volume":"35","author":"AJ Budney","year":"2008","unstructured":"Budney AJ, Vandrey RG, Hughes JR, Thostenson JD, Bursac Z (2008). Comparison of cannabis and tobacco withdrawal: severity and contribution to relapse. J Subst Abuse Treat 35: 362\u2013368.","journal-title":"J Subst Abuse Treat"},{"key":"BFnpp201214_CR7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","volume":"28","author":"DJ Buysse","year":"1989","unstructured":"Buysse DJ, Reynolds 3rd CF, Monk TH, Berman SR, Kupfer DJ (1989). The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 28: 193\u2013213.","journal-title":"Psychiatry Res"},{"key":"BFnpp201214_CR8","volume-title":"Medical Toxicology","author":"EM Caravati","year":"2003","unstructured":"Caravati EM (2003). Marijuana and other cannabinoids. In: Dart RC (ed). Medical Toxicology, 3rd edn. Lippincott Williams & Wilkins: Philadelphia, PA."},{"key":"BFnpp201214_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/10550490802408936","volume":"18","author":"KM Carpenter","year":"2009","unstructured":"Carpenter KM, McDowell D, Brooks DJ, Cheng WY, Levin FR (2009). A preliminary trial: double-blind comparison of nefazodone, bupropion-SR, and placebo in the treatment of cannabis dependence. Am J Addict 18: 53\u201364.","journal-title":"Am J Addict"},{"key":"BFnpp201214_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1080\/10550490500418997","volume":"15","author":"ML Copersino","year":"2006","unstructured":"Copersino ML, Boyd SJ, Tashkin DP, Huestis MA, Heishman SJ, Dermand JC et al (2006). Cannabis withdrawal among non-treatment-seeking adult cannabis users. Am J Addict 15: 8\u201314.","journal-title":"Am J Addict"},{"key":"BFnpp201214_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/ADM.0b013e31820c23fa","volume":"5","author":"RD Crean","year":"2011","unstructured":"Crean RD, Crane NA, Mason BJ (2011). An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions. J Addict Med 5: 1\u20138.","journal-title":"J Addict Med"},{"key":"BFnpp201214_CR12","volume-title":"Manual for the Delis-Kaplan Executive Function System (D-KEFS)","author":"D Delis","year":"2001","unstructured":"Delis D, Kramer J, Kaplan E (2001). Manual for the Delis-Kaplan Executive Function System (D-KEFS). Psychological Corporation: San Antonio, TX."},{"key":"BFnpp201214_CR13","unstructured":"Donovan DM, Bigelow GE, Brigham GS, Carroll KM, Cohen AJ, Gardin JG et al (2011). Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in clinical trials. Addiction (e-pub ahead of print)."},{"key":"BFnpp201214_CR14","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1037\/0022-006X.68.1.134","volume":"68","author":"W Fals-Stewart","year":"2000","unstructured":"Fals-Stewart W, O\u2019Farrell TJ, Freitas TT, McFarlin SK, Rutigliano P (2000). The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties. J Consult Clin Psychol 68: 134\u2013144.","journal-title":"J Consult Clin Psychol"},{"key":"BFnpp201214_CR15","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/jat\/23.6.531","volume":"23","author":"AD Fraser","year":"1999","unstructured":"Fraser AD, Worth D (1999). Urinary excretion profiles of 11-nor-9-carboxy-delta9 tetrahydrocannabinol: a delta9-THCCOOH to creatinine ratio study. J Anal Toxicol 23: 531\u2013534.","journal-title":"J Anal Toxicol"},{"key":"BFnpp201214_CR16","doi-asserted-by":"publisher","first-page":"426","DOI":"10.4088\/JCP.v59n0805","volume":"59","author":"SN Ghaemi","year":"1998","unstructured":"Ghaemi SN, Katzow JJ, Desai SP, Goodwin FK (1998). Gabapentin treatment of mood disorders: a preliminary study. J Clin Psy 59: 426\u2013429.","journal-title":"J Clin Psy"},{"key":"BFnpp201214_CR17","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1176\/appi.ajp.159.10.1642","volume":"159","author":"RZ Goldstein","year":"2002","unstructured":"Goldstein RZ, Volkow ND (2002). Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 159: 1642\u20131652.","journal-title":"Am J Psychiatry"},{"key":"BFnpp201214_CR18","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1001\/archpsyc.61.3.310","volume":"61","author":"R Gueorguieva","year":"2004","unstructured":"Gueorguieva R, Krystal JH (2004). Move over ANOVA: progress in analyzing repeated- measures data and its reflection in papers published in the Archives of General Psychiatry. Arch Gen Psychiatry 61: 310\u2013317.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp201214_CR19","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1111\/j.1528-1157.1999.tb00830.x","volume":"40","author":"CL Harden","year":"1999","unstructured":"Harden CL, Lazar LM, Pick LH, Nikolov B, Goldstein MA, Carson D et al (1999). A beneficial effect on mood in partial epilepsy patients treated with gabapentin. Epilepsia 40: 1129\u20131134.","journal-title":"Epilepsia"},{"key":"BFnpp201214_CR20","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/jat\/22.6.445","volume":"22","author":"MA Huestis","year":"1998","unstructured":"Huestis MA, Cone EJ (1998). Differentiating new marijuana use from residual drug excretion in occasional marijuana users. J Anal Toxicol 22: 445\u2013454.","journal-title":"J Anal Toxicol"},{"key":"BFnpp201214_CR21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1176\/ajp.157.1.151","volume":"157","author":"M Karam-Hage","year":"2000","unstructured":"Karam-Hage M, Brower KJ (2000). Gabapentin treatment for insomnia associated with alcohol dependence. Am J Psy 157: 151.","journal-title":"Am J Psy"},{"key":"BFnpp201214_CR22","volume-title":"Psychiatry","author":"GF Koob","year":"2008","unstructured":"Koob GF, Kandel DB, Volkow ND (2008). Psychiatric pathophysiology: addiction. In: Tasman A, Kay J, Lieberman J, First MB, Maj M (eds). Psychiatry, 3rd edn. John Wiley & Sons: West Sussex, England."},{"key":"BFnpp201214_CR23","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1038\/nn1105-1442","volume":"8","author":"GF Koob","year":"2005","unstructured":"Koob GF, Le Moal M (2005). Plasticity of reward neurocircuitry and the \u2018dark side\u2019 of drug addiction. Nature Neurosci 8: 1442\u20131444.","journal-title":"Nature Neurosci"},{"key":"BFnpp201214_CR24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev.psych.59.103006.093548","volume":"59","author":"GF Koob","year":"2008","unstructured":"Koob GF, Le Moal M (2008). Addiction and the brain antireward system. Annu Rev Psychol 59: 29\u201353.","journal-title":"Annu Rev Psychol"},{"key":"BFnpp201214_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/npp.2009.110","volume":"35","author":"GF Koob","year":"2010","unstructured":"Koob GF, Volkow ND (2010). Neurocircuitry of addiction. Neuropsychopharmacology 35: 217.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201214_CR26","doi-asserted-by":"publisher","first-page":"963","DOI":"10.2307\/2529876","volume":"38","author":"NM Laird","year":"1982","unstructured":"Laird NM, Ware JH (1982). Random-effects models for longitudinal data. Biometrics 38: 963\u2013974.","journal-title":"Biometrics"},{"key":"BFnpp201214_CR27","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.drugalcdep.2010.12.010","volume":"116","author":"FR Levin","year":"2011","unstructured":"Levin FR, Mariani JJ, Brooks DJ, Pavlicova M, Cheng W, Nunes EV (2011). Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial. Drug Alcohol Depend 116: 142\u2013150.","journal-title":"Drug Alcohol Depend"},{"key":"BFnpp201214_CR28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/10550490490265280","volume":"13","author":"FR Levin","year":"2004","unstructured":"Levin FR, McDowell D, Evans SM, Nunes E, Akerele E, Donovan S et al (2004). Pharmacotherapy for marijuana dependence: a double-blind, placebo-controlled pilot study of divalproex sodium. Am J Addict 13: 21\u201332.","journal-title":"Am J Addict"},{"key":"BFnpp201214_CR29","first-page":"343","volume":"22","author":"J Levine","year":"1986","unstructured":"Levine J, Schooler NR (1986). SAFTEE: a technique for the systematic assessment of side effects in clinical trials. Psychopharmacol Bull 22: 343\u2013381.","journal-title":"Psychopharmacol Bull"},{"key":"BFnpp201214_CR30","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/WNF.0b013e3181cda242","volume":"33","author":"HS Lo","year":"2010","unstructured":"Lo HS, Yang CM, Lo HG, Lee CY, Ting H, Tzang BS (2010). Treatment effects of gabapentin for primary insomnia. Clin Neuropharmacol 33: 84\u201390.","journal-title":"Clin Neuropharmacol"},{"key":"BFnpp201214_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2011.02.035","volume":"181","author":"R Maldonado","year":"2011","unstructured":"Maldonado R, Berrendero F, Ozaita A, Robledo P (2011). Neurochemical basis of cannabis addiction. Neuroscience 181: 1\u201317.","journal-title":"Neuroscience"},{"key":"BFnpp201214_CR32","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1369-1600.2008.00133.x","volume":"14","author":"BJ Mason","year":"2009","unstructured":"Mason BJ, Light JM, Williams LD, Drobes DJ (2009). Proof-of-concept human laboratory study for protracted abstinence in alcohol dependence: effects of gabapentin. Addict Biol 14: 73\u201383.","journal-title":"Addict Biol"},{"key":"BFnpp201214_CR33","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.drugalcdep.2009.06.022","volume":"105","author":"AL McRae-Clark","year":"2009","unstructured":"McRae-Clark AL, Carter RE, Killeen TK, Carpenter MJ, Wahlquist AE, Simpson SA et al (2009). A placebo-controlled trial of buspirone for the treatment of marijuana dependence. Drug Alcohol Depend 105: 132\u2013138.","journal-title":"Drug Alcohol Depend"},{"key":"BFnpp201214_CR34","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1521-0391.2010.00076.x","volume":"19","author":"AL McRae-Clark","year":"2010","unstructured":"McRae-Clark AL, Carter RE, Killeen TK, Carpenter MJ, White KG, Brady KT (2010). A placebo-controlled trial of atomoxetine in marijuana-dependent individuals with attention deficit hyperactivity disorder. Am J Addict 19: 481\u2013489.","journal-title":"Am J Addict"},{"key":"BFnpp201214_CR35","unstructured":"Neurontin (gabapentin) [package insert LAB-0106-9.0]. Pfizer, New York. Revised January 2007."},{"key":"BFnpp201214_CR36","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/10550490701525665","volume":"16","author":"BR Nordstrom","year":"2007","unstructured":"Nordstrom BR, Levin FR (2007). Treatment of cannabis use disorders: a review of the literature. Am J Addict 16: 331\u2013342.","journal-title":"Am J Addict"},{"key":"BFnpp201214_CR37","volume-title":"SPSS Statistics 17.0 Advanced Statistical Procedures Companion","author":"MJ Norusis","year":"2008","unstructured":"Norusis MJ (2008). SPSS Statistics 17.0 Advanced Statistical Procedures Companion. Prentice Hall Inc.: Upper Saddle River, NJ."},{"key":"BFnpp201214_CR38","doi-asserted-by":"publisher","first-page":"5762","DOI":"10.1523\/JNEUROSCI.0575-08.2008","volume":"28","author":"M Roberto","year":"2008","unstructured":"Roberto M, Gilpin NW, O\u2019Dell LE, Cruz MT, Morse AC, Siggins GR et al (2008). Cellular and behavioral interactions of gabapentin with alcohol dependence. J Neurosci 28: 5762\u20135771.","journal-title":"J Neurosci"},{"key":"BFnpp201214_CR39","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1126\/science.276.5321.2050","volume":"276","author":"F Rodriguez de Fonseca","year":"1997","unstructured":"Rodriguez de Fonseca F, Carrera MR, Navarro M, Koob GF, Weiss F (1997). Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science 276: 2050\u20132054.","journal-title":"Science"},{"key":"BFnpp201214_CR40","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1212\/01.WNL.0000152877.08088.87","volume":"64","author":"MC Salinsky","year":"2005","unstructured":"Salinsky MC, Storzbach D, Spencer DC, Oken BS, Landry T, Dodrill CB (2005). Effects of topiramate and gabapentin on cognitive abilities in healthy volunteers. Neurology 64: 792\u2013798.","journal-title":"Neurology"},{"key":"BFnpp201214_CR41","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.coph.2005.11.003","volume":"6","author":"GJ Sills","year":"2006","unstructured":"Sills GJ (2006). The mechanisms of action of gabapentin and pregabalin. Curr Opin Pharmacol 6: 108\u2013113.","journal-title":"Curr Opin Pharmacol"},{"key":"BFnpp201214_CR42","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/jat\/33.4.185","volume":"33","author":"ML Smith","year":"2009","unstructured":"Smith ML, Barnes AJ, Huestis MA (2009). Identifying new cannabis use with urine creatinine- normalized THCCOOH concentrations and time intervals between specimen collections. J Anal Toxicol 33: 185\u2013189.","journal-title":"J Anal Toxicol"},{"key":"BFnpp201214_CR43","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1037\/a0019295","volume":"18","author":"M Sofuoglu","year":"2010","unstructured":"Sofuoglu M, Sugarman DE, Carroll KM (2010). Cognitive function as an emerging treatment target for marijuana addiction. Exp Clin Psychopharmacol 18: 109\u2013119.","journal-title":"Exp Clin Psychopharmacol"},{"key":"BFnpp201214_CR44","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1037\/0022-006X.68.5.898","volume":"68","author":"RS Stephens","year":"2000","unstructured":"Stephens RS, Roffman RA, Curtin L (2000). Comparison of extended vs brief treatments for marijuana use. J Consult Clin Psychol 68: 898\u2013908.","journal-title":"J Consult Clin Psychol"},{"key":"BFnpp201214_CR45","unstructured":"Substance Abuse and Mental Health Services Administration (2007). Results from the 2006 National Survey on Drug Use and Health: National Findings (Office of Applied Studies, NSDUH Series H-32, DHHS Publication No. SMA 07-4293). SAMHSA: Rockville, MD."},{"key":"BFnpp201214_CR46","doi-asserted-by":"crossref","unstructured":"United Nations Office on Drugs and Crime (2010). World Drug Report 2010. United Nations: New York, NY.","DOI":"10.18356\/079beef9-en"},{"key":"BFnpp201214_CR47","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1177\/0163278709338554","volume":"32","author":"BT West","year":"2009","unstructured":"West BT (2009). Analyzing longitudinal data with the linear mixed models procedure in SPSS. Eval Health Prof 32: 207\u2013228.","journal-title":"Eval Health Prof"},{"key":"BFnpp201214_CR48","volume-title":"Wide Range Achievement Test-4 Professional Manual","author":"GS Wilkinson","year":"2006","unstructured":"Wilkinson GS, Robertson GJ (2006). Wide Range Achievement Test-4 Professional Manual. Psychological Assessment Resources, Inc: Lutz, FL."},{"key":"BFnpp201214_CR49","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1158\/1055-9965.EPI-09-0546","volume":"19","author":"X Xue","year":"2010","unstructured":"Xue X, Gange SJ, Zhong Y, Burk RD, Minkoff H, Massad LS et al (2010). Marginal and mixed-effects models in the analysis of human papillomavirus natural history data. Cancer Epidemiol Biomarkers Prev 19: 159\u2013169.","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp201214.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp201214","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp201214.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:42:09Z","timestamp":1684453329000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp201214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,29]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["BFnpp201214"],"URL":"https:\/\/doi.org\/10.1038\/npp.2012.14","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,29]]}}}